ロード中...
Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysis
INTRODUCTION: Nonclear cell (NCC) metastatic renal cell carcinoma (mRCC) is a biologically heterogeneous entity. We report the outcomes of NCC mRCC treated with first-line vascular endothelial growth factor (VEGF) inhibitors or mammalian target of rapamycin (mTOR) inhibitors at our institute. This i...
保存先:
| 出版年: | South Asian J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6190394/ https://ncbi.nlm.nih.gov/pubmed/30430089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_22_18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|